{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:41:51Z","timestamp":1793295711279,"version":"4.5.0"},"reference-count":164,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212785","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T17:54:31Z","timestamp":1553104471000},"page":"e0212785","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":96,"title":["Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-5834","authenticated-orcid":true,"given":"Jeffrey L.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachiyo","family":"Kuwatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nickoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilkins","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Hayashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/033310240102100708","article-title":"Epidemiology of headache","volume":"21","author":"BK Rasmussen","year":"2001","journal-title":"Cephalalgia"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11910-003-0060-7","article-title":"Epidemiology of migraine and other types of headache in Asia","volume":"3","author":"SJ Wang","year":"2003","journal-title":"Current Neurology & Neuroscience Reports"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1526-4610.2008.01263.x","article-title":"Prevalence and burden of headache and migraine in Germany","volume":"49","author":"A Radtke","year":"2009","journal-title":"Headache"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10194-006-0273-7","article-title":"Economic impact of primary headaches in Turkey: a university hospital based study: part II","volume":"7","author":"N Karli","year":"2006","journal-title":"J Headache Pain"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/S0004-282X2010000600008","article-title":"Prevalence and impact of headache in undergraduate students in Southern Brazil","volume":"68","author":"A Falavigna","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1468-2982.2003.00543.x","article-title":"The family impact of migraine: population-based studies in the USA and UK","volume":"23","author":"RB Lipton","year":"2003","journal-title":"Cephalalgia"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.2003.00546.x","article-title":"Migraine headache disability and health-related quality-of-life: a population-based case-control study from England","volume":"23","author":"RB Lipton","year":"2003","journal-title":"Cephalalgia"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0333102414552532","article-title":"The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results","volume":"35","author":"AM Adams","year":"2015","journal-title":"Cephalalgia"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","article-title":"Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study","volume":"52","author":"DC Buse","year":"2012","journal-title":"Headache"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102410381145","article-title":"Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)","volume":"31","author":"AM Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1526-4610.2010.01770.x","article-title":"Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center","volume":"50","author":"M Leonardi","year":"2010","journal-title":"Headache"},{"key":"ref12","article-title":"Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life","author":"A Raggi","year":"2010","journal-title":"Neurol Sci"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1526-4610.2008.01117_1.x","article-title":"A pivotal moment in 50 years of headache history: the first American Migraine Study","volume":"48","author":"SJ Tepper","year":"2008","journal-title":"Headache"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.clinthera.2007.05.008","article-title":"The cycle of migraine: patients&apos; quality of life during and between migraine attacks","volume":"29","author":"FG Freitag","year":"2007","journal-title":"Clin Ther"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"XH Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"ref16","first-page":"S62","article-title":"The cost of migraine and its treatment","volume":"11","author":"LD Goldberg","year":"2005","journal-title":"Am J Manag Care"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e0130733","DOI":"10.1371\/journal.pone.0130733","article-title":"A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache","volume":"10","author":"JL Jackson","year":"2015","journal-title":"Plos One"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/s10072-013-1370-4","article-title":"Prevalence of tension-type headache in adult general population: the PACE study and review of the literature","volume":"34","author":"T Ferrante","year":"2013","journal-title":"Neurological Sciences"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10654-004-6519-2","article-title":"Has the prevalence of migraine and tension-type headache changed over a 12-year period","volume":"20","author":"AC Lyngberg","year":"2005","journal-title":"European Journal of Epidemiology"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0895-4356(91)90147-2","article-title":"Epidemiology of headache in a general population\u2014A prevalence study","volume":"44","author":"BK Rasmussen","year":"1991","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.279.5.381","article-title":"Epidemiology of tension-type headache","volume":"279","author":"BS Schwartz","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","article-title":"The global burden of headache: a documentation of headache prevalence and disability worldwide","volume":"27","author":"LJ Stovner","year":"2007","journal-title":"Cephalalgia"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0333102415580099","article-title":"Quality of life in primary headache disorders: A review","volume":"36","author":"N Abu Bakar","year":"2016","journal-title":"Cephalalgia"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2005.073221","article-title":"Headache and migraine in primary care: consultation, prescription, and referral rates in a large population","volume":"77","author":"R Latinovic","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"M Linde","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"3","key":"ref26","article-title":"Anticonvulsant drugs for migraine prophylaxis","author":"E Chronicle","year":"2004","journal-title":"Cochrane Library"},{"issue":"2","key":"ref27","first-page":"CD003225","article-title":"Propranolol for migraine prophylaxis","author":"K Linde","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"ref28","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis","volume":"307","author":"JL Jackson","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1503\/cmaj.081657","article-title":"Prophylaxis of migraine headache","volume":"182","author":"T Pringsheim","year":"2010","journal-title":"CMAJ"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/j.1326-5377.1968.tb27464.x","article-title":"Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine","volume":"1","author":"JW Lance","year":"1968","journal-title":"Med J Aust"},{"issue":"3","key":"ref31","first-page":"CD002919","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches","author":"PL Moja","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"c5222","DOI":"10.1136\/bmj.c5222","article-title":"Tricyclic antidepressants and headaches: systematic review and meta-analysis","volume":"341","author":"JL Jackson","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"ref33","first-page":"S25","article-title":"Recurrent migraine: cost-effective care","volume":"44","author":"AM Rapaport","year":"1994","journal-title":"Neurology"},{"issue":"17","key":"ref34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"SD Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-2982.2004.00678.x","article-title":"Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study","volume":"24","author":"A Ferrari","year":"2004","journal-title":"Cephalalgia"},{"key":"ref36","first-page":"62","article-title":"Migraine-preventive prescription patters by specialty in ambulatory care settings in the United States","volume":"9","author":"H Takaki","year":"2017","journal-title":"Prev Med"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0333102416678382","article-title":"Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis","volume":"37","author":"Z Hepp","year":"2017","journal-title":"Cephalagia"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11606-014-3107-3","article-title":"Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999\u20132010","volume":"30","author":"JN Mafi","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1526-4610.1991.hed3105333.x","article-title":"Propranolol in the management of recurrent migraine: a meta-analytic review","volume":"31","author":"KA Holroyd","year":"1991","journal-title":"Headache"},{"issue":"2","key":"ref40","first-page":"CD003225","article-title":"Propranolol for migraine prophylaxis","author":"K Linde","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11606-013-2433-1","article-title":"Preventive pharmacologic treatments for episodic migraine in adults","volume":"28","author":"TA Shamliyan","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2982.2009.01948.x","article-title":"Guidelines for controlled trials of drugs in tension-type headache: Second edition","volume":"30","author":"L Bendtsen","year":"2010","journal-title":"Cephalalgia"},{"key":"ref45","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2","author":"JPT Higgins","year":"2011","journal-title":"Ref Type: Generic"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"Suppl 3","key":"ref47","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/00005650-198903001-00015","article-title":"Effect sizes for interpreting changes in health status","volume":"27","author":"LE Kazis","year":"1989","journal-title":"Medical Care"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"D Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/sim.4780070807","article-title":"A note on graphical presentation of estimated odds ratios from several clinical trials","volume":"7","author":"RF Galbraith","year":"1988","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"ref50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"JL Peters","year":"2006","journal-title":"JAMA"},{"issue":"7109","key":"ref53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"J Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"17","key":"ref55","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/sim.1482","article-title":"Improved tests for a random effects meta-regression with a single covariate","volume":"22","author":"G Knapp","year":"2003","journal-title":"Stat Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0900900103","article-title":"Multivariate random-effects meta-analysis","volume":"9","author":"I White","year":"2009","journal-title":"Stata Journal"},{"issue":"2","key":"ref57","first-page":"143","article-title":"A Randomized Controlled Trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the treatment of chronic tension-type facial pain","volume":"51","author":"AM Agius","year":"2013","journal-title":"A Randomized Controlled Trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the treatment of chronic tension-type facial pain"},{"key":"ref58","first-page":"263","article-title":"Propranolol in prophylaxis of migraine","volume":"82","author":"GK Ahuja","year":"1985","journal-title":"Indian J Med Res"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1468-2982.1993.1302128.x","article-title":"Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study","volume":"13","author":"HK al-Qassab","year":"1993","journal-title":"Cephalalgia"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1526-4610.1989.hed22904215.x","article-title":"Nifedipine versus propranolol for the initial prophylaxis of migraine","volume":"29","author":"GW Albers","year":"1989","journal-title":"Headache"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1981.tb04407.x","article-title":"Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study","volume":"64","author":"PG Andersson","year":"1981","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1468-2982.1983.0304207.x","article-title":"Prophylactic treatment of classical and non-classical migraine with metoprolol\u2014a comparison with placebo","volume":"3","author":"PG Andersson","year":"1983","journal-title":"Cephalalgia"},{"issue":"5","key":"ref63","first-page":"301","article-title":"A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis","volume":"118","author":"F Ashtari","year":"2008","journal-title":"A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1983.tb04561.x","article-title":"Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study","volume":"67","author":"A Baldrati","year":"1983","journal-title":"Acta Neurol Scand"},{"issue":"1340","key":"ref65","first-page":"201","article-title":"Propranolol in the treatment of migraine","volume":"224","author":"PO Behan","year":"1980","journal-title":"Practitioner"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1212\/WNL.51.5.1475","article-title":"Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test","volume":"51","author":"S Bonuso","year":"1998","journal-title":"Neurology"},{"issue":"3B","key":"ref67","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/S0004-282X1997000400003","article-title":"Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial","volume":"55","author":"CA Bordini","year":"1997","journal-title":"Arq Neuropsiquiatr"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0404.1974.tb02810.x","article-title":"Prophylactic treatment of migraine with propranolol. A clinical trial","volume":"50","author":"SE Borgesen","year":"1974","journal-title":"Acta Neurol Scand"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1526-4610.1979.hed1907379.x","article-title":"Timolol in migraine prophylaxis","volume":"19","author":"RS Briggs","year":"1979","journal-title":"Headache"},{"issue":"2","key":"ref70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.1990.1002101.x","article-title":"Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses","volume":"10","author":"JD Carroll","year":"1990","journal-title":"Cephalalgia"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/03331024870070S6204","article-title":"No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs","volume":"7","author":"C Dahlof","year":"1987","journal-title":"Cephalalgia"},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.1996.1606441.x","article-title":"Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol","volume":"16","author":"HC Diener","year":"1996","journal-title":"Cephalalgia"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1468-2982.2001.00168.x","article-title":"A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study","volume":"21","author":"HC Diener","year":"2001","journal-title":"Cephalalgia"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","article-title":"Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily","volume":"22","author":"HC Diener","year":"2002","journal-title":"Cephalalgia"},{"issue":"8","key":"ref75","first-page":"943","article-title":"Topiramate in migraine prophylaxis\u2014results from a placebo-controlled trial with propranolol as an active control","volume":"251","author":"HC Diener","year":"2004","journal-title":"J Neurol"},{"issue":"4","key":"ref76","first-page":"973","article-title":"A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine","volume":"67","author":"RB Domingues","year":"2009","journal-title":"A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1526-4610.1972.hed1201015.x","article-title":"Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis","volume":"12","author":"K Ekbom","year":"1972","journal-title":"Headache"},{"issue":"2","key":"ref78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1526-4610.1975.hed1502129.x","article-title":"Alprenolol for migraine prophylaxis","volume":"15","author":"K Ekbom","year":"1975","journal-title":"Headache"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1977.tb01423.x","article-title":"Oxprenolol in the treatment of migraine","volume":"56","author":"K Ekbom","year":"1977","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"ref80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00280110","article-title":"Nimodipine in migraine: clinical efficacy and endocrinological effects","volume":"41","author":"R Formisano","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1526-4610.1976.hed1605238.x","article-title":"Propranolol for migraine prophylaxis","volume":"16","author":"B Forssman","year":"1976","journal-title":"Headache"},{"issue":"4","key":"ref82","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1526-4610.1983.hed2304188.x","article-title":"Atenolol for migraine prophylaxis","volume":"23","author":"B Forssman","year":"1983","journal-title":"Headache"},{"issue":"4","key":"ref83","first-page":"343","article-title":"Nadolol and placebo comparison study in the prophylactic treatment of migraine","volume":"84","author":"FG Freitag","year":"1984","journal-title":"J Am Osteopath Assoc"},{"issue":"3","key":"ref84","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0317167100041962","article-title":"Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine","volume":"19","author":"MJ Gawel","year":"1992","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"ref85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1468-2982.1991.1101037.x","article-title":"Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis","volume":"11","author":"WD Gerber","year":"1991","journal-title":"Cephalalgia"},{"issue":"1","key":"ref86","first-page":"27","article-title":"Cyclandelate versus propranolol in the prophylaxis of migraine\u2014a double-blind placebo-controlled study","volume":"10","author":"WD Gerber","year":"1995","journal-title":"Funct Neurol"},{"issue":"2","key":"ref87","first-page":"144","article-title":"The prophylactic activity of propranol and nimodipineon migraine headache","volume":"8","author":"SH Ghobadi","year":"2013"},{"issue":"45","key":"ref88","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1055\/s-2008-1068322","article-title":"Betablocker vs placebo in vasomotor headache. A double-blind crossover study","volume":"112","author":"KH Grotemeyer","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"issue":"9","key":"ref89","first-page":"549","article-title":"Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study","volume":"59","author":"KH Grotemeyer","year":"1988","journal-title":"Nervenarzt"},{"issue":"10","key":"ref90","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1526-4610.1990.hed3010639.x","article-title":"Acetylsalicylic acid vs. metoprolol in migraine prophylaxis\u2014a double-blind cross-over study","volume":"30","author":"KH Grotemeyer","year":"1990","journal-title":"Headache"},{"issue":"9","key":"ref91","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1526-4610.1988.hed2809607.x","article-title":"Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg","volume":"28","author":"H Havanka-Kanniainen","year":"1988","journal-title":"Headache"},{"issue":"6","key":"ref92","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1600-0404.1986.tb07873.x","article-title":"The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients","volume":"74","author":"C Hedman","year":"1986","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"ref93","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.1994.tb01102.x","article-title":"Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation","volume":"235","author":"J Hesse","year":"1994","journal-title":"J Intern Med"},{"issue":"25","key":"ref94","first-page":"1115","article-title":"Propranolol for prophylaxis of migraine","volume":"72","author":"B Holdorff","year":"1977","journal-title":"Medizinische Klinik"},{"issue":"7776","key":"ref95","first-page":"769","article-title":"Effect of preventive (\u00ce<sup>2<\/sup> blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial","volume":"341","author":"KA Holroyd","year":"2010"},{"issue":"7","key":"ref96","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1526-4610.1987.hed2707372.x","article-title":"Atenolol in migraine prophylaxis a double-blind cross-over multicentre study","volume":"27","author":"V Johannsson","year":"1987","journal-title":"Headache"},{"issue":"5","key":"ref97","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0404.1986.tb04591.x","article-title":"Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis","volume":"73","author":"RH Johnson","year":"1986","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"ref98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1468-2982.1984.0402091.x","article-title":"Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study","volume":"4","author":"P Kangasniemi","year":"1984","journal-title":"Cephalalgia"},{"issue":"4","key":"ref99","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1468-2982.1987.0704231.x","article-title":"Classic migraine: effective prophylaxis with metoprolol","volume":"7","author":"P Kangasniemi","year":"1987","journal-title":"Cephalalgia"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1983.tb04836.x","article-title":"Femoxetine\u2014a new 5-HT uptake inhibitor\u2014and propranolol in the prophylactic treatment of migraine","volume":"68","author":"PJ Kangasniemi","year":"1983","journal-title":"Acta neurologica Scandinavica"},{"issue":"9","key":"ref101","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1997.00550210071015","article-title":"A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura","volume":"54","author":"RG Kaniecki","year":"1997","journal-title":"Arch Neurol"},{"issue":"6","key":"ref102","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0404.1980.tb01504.x","article-title":"Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.","volume":"61","author":"B Kass","year":"1980","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"ref103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ctim.2005.04.004","article-title":"Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine","volume":"13","author":"R Kaushik","year":"2005","journal-title":"Complement Ther Med"},{"issue":"6","key":"ref104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1600-0404.1994.tb02664.x","article-title":"Tolfenamic acid versus propranolol in the prophylactic treatment of migraine","volume":"89","author":"MJ Kjaersgard Rasmussen","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"ref105","first-page":"50","article-title":"An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches","volume":"5","author":"JA Klapper","year":"1994","journal-title":"HEADACHE Q"},{"issue":"6","key":"ref106","first-page":"937","article-title":"Sodium valproate versus propranolol in the prophylactic treatment of migraine","volume":"29","author":"W Kozubski","year":"1995","journal-title":"Neurol Neurochir Pol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/03331024870070S6203","article-title":"Prophylactic treatment of migraine with long acting propranolol\u2014a comparison with placebo","volume":"7","author":"A Kuritzky","year":"1987","journal-title":"Cephalalgia"},{"issue":"2","key":"ref108","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1526-4610.1985.hed2502107.x","article-title":"Clomipramine and metoprolol in migraine prophylaxis\u2014a double-blind crossover study","volume":"25","author":"HD Langohr","year":"1985","journal-title":"Headache"},{"issue":"3","key":"ref109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1468-2982.1985.0503159.x","article-title":"Metoprolol v. clonidine in the prophylactic treatment of migraine","volume":"5","author":"P Louis","year":"1985","journal-title":"Cephalalgia"},{"issue":"Suppl 8","key":"ref110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/03331024880080S805","article-title":"Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients","volume":"8","author":"CH Lucking","year":"1988","journal-title":"Cephalalgia"},{"issue":"4","key":"ref111","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1526-4610.1989.hed22904219.x","article-title":"Flunarizine and propranolol in the treatment of migraine","volume":"29","author":"HP Ludin","year":"1989","journal-title":"Headache"},{"issue":"43","key":"ref112","first-page":"1585","article-title":"Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine","volume":"121","author":"CP Maissen","year":"1991","journal-title":"Schweiz Med Wochenschr"},{"issue":"4","key":"ref113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1526-4610.1973.hed1204163.x","article-title":"Propranolol prophylaxis of migraine","volume":"12","author":"BP Malvea","year":"1973","journal-title":"Headache"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","article-title":"Prophylaxis of migraine and mixed headache. A randomized controlled study","volume":"21","author":"NT Mathew","year":"1981","journal-title":"Headache"},{"issue":"4","key":"ref115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0404.1986.tb03299.x","article-title":"Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo","volume":"73","author":"B Mikkelsen","year":"1986","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"ref116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1526-4610.1986.hed2604175.x","article-title":"Propranolol in the prophylaxis of migraine","volume":"26","author":"JW Nadelmann","year":"1986","journal-title":"Headache"},{"issue":"3","key":"ref117","first-page":"223","article-title":"Oral riboflavin versus oral propranolol in migraine prophylaxis: An open label randomized controlled trial","volume":"16","author":"NJ Nambiar","year":"2011"},{"issue":"1","key":"ref118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1526-4610.1978.hed1801020.x","article-title":"A double blind trial of acebutolol for migraine prophylaxis","volume":"18","author":"RN Nanda","year":"1978","journal-title":"Headache"},{"issue":"10","key":"ref119","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1526-4610.1986.hed2610490.x","article-title":"Nadolol and propranolol in migraine management","volume":"26","author":"B Olerud","year":"1986","journal-title":"Headache"},{"issue":"3","key":"ref120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1984.tb00815.x","article-title":"Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study","volume":"70","author":"JE Olsson","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"ref121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1742-1241.1983.tb08456.x","article-title":"Prophylactic propranolol in the treatment of headache","volume":"37","author":"TG Palferman","year":"1983","journal-title":"Br J Clin Pract"},{"issue":"3","key":"ref122","first-page":"273","article-title":"Propranolol and migraine. A clinical trial","volume":"3","author":"E Pita","year":"1977","journal-title":"Arch Farmacol Toxicol"},{"issue":"4","key":"ref123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-2982.1989.904247.x","article-title":"Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study","volume":"9","author":"A Pradalier","year":"1989","journal-title":"Cephalalgia"},{"issue":"2","key":"ref124","first-page":"89","article-title":"Nadolol and placebo comparison study in the prophylactic treatment of migraine","volume":"24","author":"RE Ryan Sr.","year":"1982","journal-title":"Panminerva Med"},{"issue":"4","key":"ref125","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/0002-8703(84)90600-8","article-title":"Comparative study of nadolol and propranolol in prophylactic treatment of migraine","volume":"108","author":"RE Ryan Sr.","year":"1984","journal-title":"Am Heart J"},{"issue":"6","key":"ref126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1526-4610.1985.hed2506320.x","article-title":"A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache","volume":"25","author":"J Sargent","year":"1985","journal-title":"Headache"},{"issue":"1","key":"ref127","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1526-4610.2007.00785.x","article-title":"Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?","volume":"48","author":"R Schellenberg","year":"2008","journal-title":"Headache"},{"issue":"2","key":"ref128","first-page":"75","article-title":"A comparative trial of flunarizine and propranolol in the prevention of migraine","volume":"77","author":"CJ Shimell","year":"1990","journal-title":"S Afr Med J"},{"issue":"13","key":"ref129","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.0b013e31824d5846","article-title":"Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine","volume":"78","author":"SD Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"ref130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1468-2982.2007.01377.x","article-title":"Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study","volume":"27","author":"M Siniatchkin","year":"2007","journal-title":"Cephalalgia"},{"issue":"10","key":"ref131","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1526-4610.1991.hed3110650.x","article-title":"Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability","volume":"31","author":"PS Sorensen","year":"1991","journal-title":"Headache"},{"key":"ref132","first-page":"45","article-title":"Flunarizine versus propranolol in interval treatment of migraine","volume":"9","author":"D Soyka","year":"1990","journal-title":"Nervenheilkunde"},{"issue":"3","key":"ref133","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1982.0203165.x","article-title":"The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine","volume":"2","author":"B Standnes","year":"1982","journal-title":"Cephalalgia"},{"issue":"1","key":"ref134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2524.1988.hed2801015.x","article-title":"Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up","volume":"28","author":"TJ Steiner","year":"1988","journal-title":"Headache"},{"issue":"18","key":"ref135","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.1984.03350180030025","article-title":"Migraine prevention with timolol. A double-blind crossover study","volume":"252","author":"S Stellar","year":"1984","journal-title":"JAMA"},{"issue":"3","key":"ref136","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.1976.tb04342.x","article-title":"Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine","volume":"53","author":"P Stensrud","year":"1976","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"ref137","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.1980.h2004006.x","article-title":"Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine","volume":"20","author":"P Stensrud","year":"1980","journal-title":"Headache"},{"issue":"7","key":"ref138","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study","volume":"34","author":"LJ Stovner","year":"2013","journal-title":"Cephalalgia"},{"issue":"10","key":"ref139","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1526-4610.2006.00598.x","article-title":"Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis","volume":"46","author":"A Streng","year":"2006","journal-title":"Headache"},{"issue":"8","key":"ref140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1526-4610.1987.hed2708421.x","article-title":"Comparative efficacy of nadolol and propranolol in the management of migraine","volume":"27","author":"A Sudilovsky","year":"1987","journal-title":"Headache"},{"issue":"1","key":"ref141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","article-title":"Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.","volume":"69","author":"P Tfelt-Hansen","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"ref142","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1468-2982.1997.1705596.x","article-title":"Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study","volume":"17","author":"LL van de Ven","year":"1997","journal-title":"Cephalalgia"},{"issue":"1","key":"ref143","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-2982.1985.0501017.x","article-title":"Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation","volume":"5","author":"S Vilming","year":"1985","journal-title":"Cephalalgia"},{"key":"ref144","first-page":"404","article-title":"The treatment of migraine with propranolol","volume":"21","author":"RB Weber","year":"1971","journal-title":"Neurology"},{"issue":"5921","key":"ref145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.2.5921.699","article-title":"Propranolol in the treatment of migraine","volume":"2","author":"TE Wideroe","year":"1974","journal-title":"Br Med J"},{"issue":"14","key":"ref146","first-page":"268","article-title":"Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol","volume":"110","author":"R Worz","year":"1992","journal-title":"Fortschr Med"},{"issue":"3","key":"ref147","first-page":"111","article-title":"A pilot study of the value of propranolol in migraine","volume":"21","author":"KG Nair","year":"1975","journal-title":"J Postgrad Med"},{"issue":"1","key":"ref148","first-page":"119","article-title":"Clinical study of topiramate in preventing migraine attacks","volume":"30","author":"J Chen","year":"2009","journal-title":"Sichuan Medical Journal"},{"issue":"8","key":"ref149","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archneur.1993.00540080036010","article-title":"Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects","volume":"50","author":"DK Ziegler","year":"1993","journal-title":"Arch Neurol"},{"issue":"14","key":"ref150","first-page":"24","article-title":"Therapeutic effect of metoprolol tartrate combined with flunarizine on migraine in the treatment of migraine","volume":"25","author":"X Gong","year":"2016","journal-title":"Journ of Integrative Medicine, Cardiovascular and Cerebrovascular Diseases"},{"issue":"12","key":"ref151","first-page":"760","article-title":"Sibiling combined with propranolol to treat migraine","volume":"15","author":"D Ke","year":"2003","journal-title":"Modern Practical Medicine"},{"issue":"5","key":"ref152","first-page":"120","article-title":"Double-blind therapeutic effect of \u00e2-blockers on menopausal migraine","volume":"9","author":"P Li","year":"2006","journal-title":"Chinese Journal of Practical Nervous Diseases"},{"issue":"4","key":"ref153","first-page":"416","article-title":"Therapeutic effect of sodium valproate on prevention of migraine recurrence","volume":"25","author":"S Li","year":"2004","journal-title":"Sichuan Medical Journal"},{"issue":"11","key":"ref154","first-page":"1275","article-title":"Therapeutic effect of metoprolol tartrate combined with flunarizine on migraine in the treatment of migraine","volume":"23","author":"W Ma","year":"2011","journal-title":"Modern Practical Medicine"},{"issue":"6","key":"ref155","first-page":"141","article-title":"Clinical effect analysis of sibelium prophylactic treatment of migraine","volume":"22","author":"JB Wen","year":"2016","journal-title":"Contemporary Medicine"},{"issue":"24","key":"ref156","first-page":"4760","article-title":"Observation on the efficacy of propranolol in preventing menopausal migraine","volume":"6","author":"Y Yang","year":"2006","journal-title":"Chinese Journal of Misdiagnosis"},{"issue":"6","key":"ref157","first-page":"109","article-title":"The effect of metoprolol combined with fluoxetine on preventing migraine and its effect on serotonin","volume":"10","author":"Y Yang","year":"2016","journal-title":"Chinese Journal of Modern Drug Application"},{"issue":"2","key":"ref158","first-page":"182","article-title":"Preliminary randomized controlled trial of topiramate and propranolol to prevent migraine attacks","volume":"20","author":"Q Yuan","year":"2005","journal-title":"Huaxi Pharmaceutical Journal"},{"issue":"10","key":"ref159","first-page":"836","article-title":"The efficacy of metoprolol combined with fluoxetine in preventing migraine","volume":"14","author":"J Zhou","year":"2015","journal-title":"Journal of Clinical and Experimental Medicine"},{"issue":"1","key":"ref160","first-page":"51","article-title":"Therapeutic effect of sibelium on migraine","volume":"26","author":"J Zhu","year":"2005","journal-title":"Journal of Medical Forum"},{"issue":"5","key":"ref161","first-page":"419","article-title":"A clinical study of Sibelium combining Topiramate in prophylactic treatment of migraine","volume":"19","author":"Z Li","year":"2002","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"issue":"1","key":"ref162","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.1972.tb07532.x","article-title":"Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis","volume":"48","author":"O Sjaastad","year":"1972","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"ref163","first-page":"523","article-title":"Clinical trial of propranolol and amitriptyline in the treatment of migraine","volume":"31","author":"H Dongxiang","year":"2010","journal-title":"Yunnan Medicine"},{"issue":"5","key":"ref164","first-page":"419","article-title":"A clinical study of sibelium combining topiramate in prophylactic treatment of migraine","volume":"19","author":"Z Li","year":"2002","journal-title":"Chinese JMAP"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T23:31:14Z","timestamp":1721086274000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212785"}},"subtitle":[],"editor":[{"given":"Chun Shing","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":164,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212785","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]}}}